Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12619000929101
ACTRN12619000929101
Terminated
未知

Assessing a time course of plasma myeloperoxidase, a marker of oxidative stress, following a high fat high carbohydrate meal in healthy males

Monash University0 sites12 target enrollmentJuly 3, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOxidative stressMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - Other diet and nutrition disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Oxidative stress
Sponsor
Monash University
Enrollment
12
Status
Terminated
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2019
End Date
November 27, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Body mass index between the range of 18\.5 to 25\.0 kg/m2
  • •Blood pressure between 90/60 and 140/90 mmHg
  • •Aged between 18 and 35 years
  • •Non\-smoker

Exclusion Criteria

  • •Body mass index outside the range of 18\.5 to 25\.0 kg/m2
  • •Blood pressure below 90/60 or above 140/90 mmHg
  • •Taking medications with antioxidant activity or that may affect absorption of phytochemicals
  • •Taking nutritional supplements with antioxidant activity
  • •Diagnosed with a medical condition
  • •Consume greater than 14 standard drinks of alcohol per week
  • •Has an implanted cardiac defibrillator
  • •Has any dietary allergies/intolerances that prevent consuming study meals

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
A clinical trial to study the association between reactive oxygen species and semen quality and the effect of vitamin C therapy in male infertility patients
CTRI/2019/03/018303Dr V Radha
Completed
Not Applicable
Estimation of the activity of marker enzymes ( Paraoxonase 1,Myeloperoxidase) in serum and their relationship with Atherogenic Index of Plasma in patients with abnormal lipid levelsHealth Condition 1: I709- Other and unspecified atherosclerosis
CTRI/2019/01/017177Tejal Deepak Durgekar143
Not yet recruiting
Phase 1
Estimation of protein levels in the saliva before and after scaling and root planing procedure
CTRI/2020/04/024689Rinu Reju
Not yet recruiting
Not Applicable
The influence of myeloperoxidase-deficiency on the vasculatureMyeloperoxidase deficiency, parodontits, chronic inflammationEndothelial Dysfunction
DRKS00019108Medizinische Klinik III, Herzzentrum der Universität zu Köln200
Completed
Not Applicable
Plasma Myeloperoxidase Levels in Patients With Coronary Artery DiseaseCoronary Artery Disease
NCT01239979Isfahan University of Medical Sciences150